US Patent Issued to Kite Pharma on May 12 for "Chimeric antigen and t cell receptors and methods of use" (California, New Hampshire Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,105, issued on May 12, was assigned to Kite Pharma Inc. (Santa Monica, Calif.). "Chimeric antigen and t cell receptors and methods of use" w... Read More

US Patent Issued to Amgen on May 12 for "Combination of LILRB1/2 pathway inhibitors and PD-1 pathway inhibitors" (Canadian, American Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,106, issued on May 12, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Combination of LILRB1/2 pathway inhibitors and PD-1 pathway inhi... Read More

US Patent Issued to Bristol-Myers Squibb on May 12 for "Cancer immunotherapy by disrupting PD-1/PD-L1 signaling" (Pennsylvania, Maryland, New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,107, issued on May 12, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.). "Cancer immunotherapy by disrupting PD-1/PD-L1 signaling"... Read More

US Patent Issued to New York University, PureTech LYT on May 12 for "Anti-galectin-9 antibodies and uses thereof" (American, British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,108, issued on May 12, was assigned to New York University (New York) and PureTech LYT Inc. (Boston). "Anti-galectin-9 antibodies and uses t... Read More

US Patent Issued to ABL Bio on May 12 for "Antibody to insulin-like growth factor 1 receptor (IGF1R) and related compositions and uses" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,110, issued on May 12, was assigned to ABL Bio Inc. (Seongnam-si, South Korea). "Antibody to insulin-like growth factor 1 receptor (IGF1R) a... Read More

US Patent Issued to CytoDyn on May 12 for "Methods for treating metastatic colon cancer with leronlimab" (Washington Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,111, issued on May 12, was assigned to CytoDyn Inc. (Vancouver, Wash.). "Methods for treating metastatic colon cancer with leronlimab" was i... Read More

US Patent Issued to MABWELL (SHANGHAI) BIOSCIENCE on May 12 for "Anti-ST2 antibody, encoding nucleic acid molecules thereof and methods of use thereof" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,112, issued on May 12, was assigned to MABWELL (SHANGHAI) BIOSCIENCE Co. LTD. (Shanghai). "Anti-ST2 antibody, encoding nucleic acid molecule... Read More

US Patent Issued to KYOWA KIRIN, KYOTO UNIVERSITY on May 12 for "Anti-human CCR1 monoclonal antibody" (Japanese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,113, issued on May 12, was assigned to KYOWA KIRIN Co. LTD. (Tokyo) and KYOTO UNIVERSITY (Kyoto, Japan). "Anti-human CCR1 monoclonal antibod... Read More

US Patent Issued to Regeneron Pharmaceuticals on May 12 for "Method of reducing serum amyloid a (SAA) protein levels in a patient by administering an interleukin-33 (IL-33) antibody" (American, French Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,114, issued on May 12, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Method of reducing serum amyloid a (SAA) protein l... Read More

US Patent Issued to Regeneron Pharmaceuticals on May 12 for "Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies" (New York, New Jersey Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,115, issued on May 12, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Stabilized formulations containing anti-interleuki... Read More

• ««
• «
• 12353
• 12354
• 12355
• 12356
• 12357
• 12358
• 12359
• 12360
• 12361
• 12362
• »
• »»